These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11165100)

  • 21. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
    Han M; Fang XL
    Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin.
    Gyürösiová L; Laitinen L; Raiman J; Cizmárik J; Sedlárová E; Hirvonen J
    Pharm Res; 2002 Feb; 19(2):162-8. PubMed ID: 11883643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations.
    Corrigan OI
    Adv Exp Med Biol; 1997; 423():111-28. PubMed ID: 9269487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of physical properties, screening procedures and a human efficacy trial for predicting the bioavailability of commercial elemental iron powders used for food fortification.
    Lynch SR; Bothwell T;
    Int J Vitam Nutr Res; 2007 Mar; 77(2):107-24. PubMed ID: 17896584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
    Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutical studies on hydantoin derivatives. I. Physico-chemical properties of hydantoin derivatives and their intestinal absorption.
    Fujioka H; Tan T
    J Pharmacobiodyn; 1981 Oct; 4(10):759-70. PubMed ID: 7320829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
    Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
    Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines.
    Thwaites DT; Hirst BH; Simmons NL
    Pharm Res; 1993 May; 10(5):674-81. PubMed ID: 8321830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport kinetics of iron chelators and their chelates in Caco-2 cells.
    Huang XP; Spino M; Thiessen JJ
    Pharm Res; 2006 Feb; 23(2):280-90. PubMed ID: 16388408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal absorption of drugs: methods and studies.
    Barthe L; Woodley J; Houin G
    Fundam Clin Pharmacol; 1999; 13(2):154-68. PubMed ID: 10226759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopharmaceutics classification evaluation for paris saponin VII.
    Zhang X; Sun Y; Cheng Y; Ye WL; Zhang BL; Mei QB; Zhou SY
    Chin J Nat Med; 2020 Sep; 18(9):714-720. PubMed ID: 32928515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.
    Siccardi D; Kandalaft LE; Gumbleton M; McGuigan C
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1112-9. PubMed ID: 14557377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers.
    Gan LS; Hsyu PH; Pritchard JF; Thakker D
    Pharm Res; 1993 Dec; 10(12):1722-5. PubMed ID: 8302757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication.
    Stratford RE; Clay MP; Heinz BA; Kuhfeld MT; Osborne SJ; Phillips DL; Sweetana SA; Tebbe MJ; Vasudevan V; Zornes LL; Lindstrom TD
    J Pharm Sci; 1999 Aug; 88(8):747-53. PubMed ID: 10430536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.